On 22nd and 23rd of October 2020, Tecnimede participated in the fourth annual meeting of the Geriatrics Nucleus of Internal Medicine.

During this meeting, Tecnimede highlighted the drug Molinar, a drug researched and developed by the Tecnimede Group, which is indicated for the prevention and treatment of vitamin D deficiency in adults. It is the first tablet formulation to be taken monthly.